Improved growth and decreased morbidities in <1000g neonates after early management changes

Journal of Perinatology

Volumn 28, Issue 5, 2008, Pages 347-353

  Geary, C A ^a   Fonseca, R A ^a   Caskey, M A ^a   Malloy, M H ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Delivery room CPAP; Early amino acids; Extra uterine growth restriction; Neonatal nutrition and growth; Neurodevelopmental delay; Surfactant

Indexed keywords

AMINO ACID; OXYGEN;

ARTICLE; BODY WEIGHT; CHILD CARE; CHILD GROWTH; COHORT ANALYSIS; COLON SURGERY; CONTROLLED STUDY; EARLY INTERVENTION; EXTRA UTERINE GROWTH RESTRICTION; EXTREMELY LOW BIRTH WEIGHT; EXTUBATION; FEMALE; GROWTH RETARDATION; HUMAN; INCIDENCE; INFANT; INFANT FEEDING; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NECROTIZING ENTEROCOLITIS; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PATIENT SAFETY; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; TREATMENT DURATION;

AMINO ACIDS; BIRTH WEIGHT; COHORT STUDIES; CONTINUOUS POSITIVE AIRWAY PRESSURE; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE, NEONATAL; MALE; OXYGEN; PARENTERAL NUTRITION, TOTAL; PULMONARY SURFACTANTS; TREATMENT OUTCOME;

EID: 43049105783     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2008.15     Document Type: Article

References (36)

1. Kilbride HW, Wirtschafter DD, Powers RJ, Sheehan MB. Implementation of evidence-based potentially better practices to decrease nosocomial infections. Pediatrics 2003; 111: 519-533.
2. Zabari M, Suresh G, Tomlinson M, Lavin JP, Larison K, Halamek L et al Implementation and case-study results of potentially better practices for collaboration between obstetrics and neonatology to achieve improved perinatal outcomes. Pediatrics 2006; 118: 153-158.
3. Ohlinger J, Kantak A, Lavin JP, Fofah O. Hagen E, Suresh G et al. Evaluation and development of potentially better practices for perinatal and neonatal communication and collaboration. Pediatrics 2006; 118: 147-152.
4. Kaempf JW, Campbell B, Sklar RS, Arduza C, Gallegos R, Zabari M et al Implementing potentially better practices th improve neonatal outcomes after reducing postnatal dexamethasone use in infants born between 501-1250 grams. Pediatrics 2003; 111: 534-541.
5. Kuzma-O'Reilly B, Duenas ML, Greecher C, Kimberlin L, Mujsce D, Miller D et al. Evaluation, development, and implementation of potentially better practices in neonatal intensive care nutrition. Pediatrics 2003; 111: 461-470.
6. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestational age. J Pediatr 1967; 71: 159-163.
7. Kirchner L, Weninger M, Unterasinger L, Birnbacher R, Hayde M, Krepler R et al. Is the use of early nasal CPAP associated with lower rates of chronic lung disease and retinopathy of prematurity? Nine years experience with the Vermont oxford neonatal network. J Perinat Med 2004; 33 (1): 60-66.
8. Deulofeut R, Critz A, Adams-Chapman I, Sola A. Avoiding hyperoxia in infants ≤ 1250 g is associated width improved short- and long-term outcomes. J Perinatol 2006; 26: 700-705.
9. The STOP-ROP Multicenter Study Group: Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP), a randombed, controlled trial. Pediatrics 2000; 105(2): 295-310.
10. Hay WW. Early postnatal nutritional rquirements of the very preterm infant based on a presentation at the NICHD-AAP workshop on research in neonatology. J Perinatol 2006; 26: 13-18.
11. Thureen PJ, Anderson AH, Baron KA, Melara, DL, Hay WW, Fennessey PV. Protein balance in the first week of life in ventilated neonates receiving parenteral nutrition. Am J Clin Nutr 1998; 68: 1128-1135.
12. Akram Khan M, Kuzma-O'Reilly B, Brodsky NL, Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol 2006; 26(7): 428-435.
13. Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 30 (4): 200-208.
14. Frank L, Sosenko IR. Undernutrition as a major contributing factor in the pathogenesis of bronchopulmonary dysplasia. Am Rev Respir Dis 1988 138(3): 725-729.
15. Thureen P, Melara D, Fennessey P, Hay W. Effect oflow, versus high intravenous amino acid intake on very low birth weight infants in the early neonatal period. Pediatr Res 2003; 53(1): 24-32.
16. Thureen PJ, Hay WW. Intravenous nutrition and postnatal growth of the micropremie. Clin Perinatol 2000; 27: 197-219.
17. Ehrenkranz RA Younes N, Lemons JA, Fanaroff AA, Donovan EF, Wright LL et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999; 104: 280-289.
18. Latal-Hajnal B, Von Siebenthal K, Kovari H, Bucher HU, Largo RH. Postnatal growth in VLBW infants: Significant association with neurodevelopmental outcome. J Pediatr 2003; 143: 163-170.
19. Peralta-Carcelen M, Jackson DS, Goran MI, Royal SA, Mayo MS, Nelson KG. Growth of adolescents who were born at extremely low birth weight without major disability. J Pediatr 2000; 136: 633-640.
20. Wood NS, Costeloe K, Gibson AT, Hennessy EM, Marlow N, Wilkinson AR. The EPICure study: Growth and associated problems in children born at 25 weeks of gestational age or less. Arch Dis Child Fetal Neonatal Ed 2003; 88: 492-500.
21. Ehrenkranz RA, Walsh MC, Vohr VR, Jobe AH, Wright LL, Fanaroff AA et al. Validation of the national institute of health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116 1353-1360.
22. Hintz SR, Kendrick DE, Stoll BJ, Vohr BR, Fanaroff AA Donovan EF et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115: 696-703.
23. Walsh MC, Kliegman RM, Hack M. Severity of necrotizing enterocolitis: influence on outcome at 2 years of age. Pediatrics 1999; 84: 808-814.
24. Jackson JK Biondo DJ, Jones JM, Moor PJ, Simon SD, Hall RT et al. Can an alternative umbilical arterial catheter solution and flush regimen decrease iatrogenic hemolysis while enhancing nutrition? A double-blind, randomized clinical trial comparing an isotonic amino acid with a hypotonic salt infusion. Pediatrics 2004; 114: 377-383.
25. Geary C, Caskey M, Fonseca R, Malloy M. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acids administration: An historical cohort study. Pediatrics 2008; 121: 89-96.
26. Kotsopoulos K, Benadiba-Torch A, Cuddy A, Shah PS. Safety and efficacy of early amino acids in preterm <28 weeks gestation: Prospective observational comparison. J Perinatol 2006; 26: 749-754.
27. Wilson DC, Cairns P, Halliday HL, Reid M, McClure G, Dodge JA. Randomized controlled trial of an aggressive nutritional regimen in sick very low birth weight infants. Arch Dis Child 1997; 77: 4-11.
28. Pauls J, Bauer K, Versmold H. Postnatal body weight curves for infants below 1000 g birth weight receiving early enteral and parenteral nutrition. Eur J Pediatr. 1998; 157: 416-421.
29. Poindexter BB, Langer JC, Dusick AM, Ehrenkranz RA. Early provision of parenteral amino acids in extremely low birth weight infants: Relation to growth and neurodevelopmental outcome. J Pediatr 200; 148 300-305.
30. Heird WC. Determination of nutritional requirements in preterm infants, with special reference to 'catch up' growth. Semin Neonatol 2001; 6: 365-375.
31. Hack M, Breslau N, Weismann B, Aram D, Klein N, Borawski E. Effect of VLBW and subnormal head size on cognitive abilities at school age. N Engl J Med 1991; 325: 231-237.
32. Short EJ, Klein NY, Lewis BA, Fulton S, Elsengart S, Kercsmar C et al Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003; 112: 359-366.
33. Vohr B, Wright L, Dusick A, Perritt R, Poole K, Tyson J et al. Center differences and outcomes of extremely low birth weight infants. Pediatrics 2004; 113: 781-789.
34. O'Shea MT, Goldstein DJ, DeRegnier RA, Sheaffer CI, Robert DD, Dillard RG. Outcome at 4-5 years of age in children recovered from neonatal chronic lung disease. Dev Med Child Neurol 1996; 38: 830-839.
35. Van Goudoever JB, Waltimena JDL, Carnielli VP, Sulkers EJ, Degenhart HJ, Sauer PJ. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia.J Pediatr 1994; 124: 112-118.
36. Gregoire MC, Lefebvre F: Glorieux J. Health and developmental outcomes at 18 month in very preterm infants with bronchopulmonary dysplasia. Pediatrics 1998; 101: 856-860.